0.29p+0.00 (+0.00%)05 Dec 2025, 12:40
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Physiomics PLC Fundamentals

Company NamePhysiomics PLCLast Updated2025-12-05
IndustryBiotechnologySectorHealthcare
Shares in Issue303.209 mMarket Cap£879,305.28
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.2887Cash Equity Ratio0.6664
Quick Ratio4.1256Current Ratio4.38
Price To Book Value1.2703ROCE0

Physiomics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Physiomics PLC Company Financials

Assets2025202420232022
Tangible Assets£12,800.00£16,829.00£7,757.00£14,365.00
Intangible Assets£3,280.00£4,379.00£5,479.00£3,005.00
Investments0000
Total Fixed Assets£16,080.00£21,208.00£13,416.00£17,765.00
Stocks0000
Debtors£363,280.00£150,922.00£147,781.00£271,155.00
Cash & Equivalents£461,242.00£191,072.00£416,592.00£687,674.00
Other Assets0000
Total Assets£892,026.00£422,603.00£674,393.00£1.12 m
Liabilities2025202420232022
Creditors within 1 year£199,855.00£140,076.00£142,673.00£140,609.00
Creditors after 1 year0000
Other Liabilities0000
Total Liabilities£199,855.00£140,076.00£142,673.00£140,609.00
Net assets£692,171.00£282,527.00£531,720.00£974,807.00
Equity2025202420232022
Called up share capital£1.21 m£541,890.00£389,699.00£389,699.00
Share Premium£6.27 m£6.12 m£5.94 m£5.94 m
Profit / Loss-£457,269.00-£668,754.00-£572,009.00-£358,972.00
Other Equity£692,171.00£282,527.00£531,720.00£974,807.00
Preference & Minorities0000
Total Capital Employed£692,171.00£282,527.00£531,720.00£974,807.00
Ratios2025202420232022
Debt Ratio0000
Debt-to-Equity0000
Assets / Equity1.28871.28871.28871.2887
Cash / Equity0.66640.66640.66640.6664
EPS£-0.00£-0.00£-0.00£-0.00
Cash Flow2025202420232022
Cash from operating activities-£546,143.00-£548,133.00-£266,587.00-£349,393.00
Cashflow before financing£273,583.00-£210,305.00-£266,587.00-£346,548.00
Increase in Cash£270,170.00-£225,520.00-£271,082.00-£355,776.00
Income2025202420232022
Turnover£784,005.00£543,250.00£597,354.00£830,266.00
Cost of sales0000
Gross Profit0000
Operating Profit-£457,791.00-£670,816.00-£573,733.00-£359,114.00
Pre-Tax profit-£457,269.00-£668,754.00-£572,009.00-£358,972.00

Physiomics PLC Company Background

SectorHealthcare
ActivitiesPhysiomics PLC is a United Kingdom-based firm that provides consulting services to biopharmaceutical companies and research institutes in the areas of outsourced modelling and simulation (quantitative pharmacology), biometrics, and data science (bioinformatics). Its business activities involve the use of industry-standard technologies and a proprietary technology platform called Virtual Tumour. The company has three service lines: Biometrics, Modelling and Simulation (Quantitative Pharmacology) and Personalised Medicine. It derives revenue from the UK, the European Union and Switzerland.
Latest Interim Date6 Mar 2025
Latest Fiscal Year End Date29 Sep 2025

Physiomics PLC Directors

AppointedNamePosition
2024-05-31Dr. Christophe D ChassagnoleExecutive Director,Chief Scientific Officer
2022-02-23Dr. Paul Bernard HarperNon-Executive Director,Chairman
2007-06-30Mr. John Kingston PoolNon-Executive Director,Chairman
2006-08-29Mr. Duncan John LipscombeNon-Executive Director
2017-11-09Mr. Mark Philip ChadwickNon-Executive Director
2025-11-13Dr. James Simon MillenNon-Executive Director,Chairman
2025-11-13Dr. Peter Joseph SargentExecutive Director,Chief Executive Officer

Physiomics PLC Contact Details

Company NamePhysiomics PLC
AddressThe Magdalen Centre, Robert Robinson Avenue, Oxford, OX4 4GA
Telephone+44 1865784980
Websitehttps://www.physiomics.co.uk

Physiomics PLC Advisors

StockbrokerHybridan LLP
Phone+44 203764 2341
Fax+44 2076001586
Financial AdviserWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897
AuditorShipleys LLP
Phone+44 2073120000
Fax+44 2073120022
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserCommunications Portfolio (The)
Phone020 7536 2028
StockbrokerWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897
SolicitorTaylor Vinters
Phone+44 1223423444
Fax+44 1223423486
Nominated AdviserWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897